Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1986 1
1987 3
1988 1
1989 3
1990 1
1991 2
1992 2
1993 5
1994 3
1995 2
1996 2
1997 7
1998 2
1999 11
2000 5
2001 9
2002 8
2003 5
2004 1
2007 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

78 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacokinetics of alendronate.
Porras AG, Holland SD, Gertz BJ. Porras AG, et al. Among authors: gertz bj. Clin Pharmacokinet. 1999 May;36(5):315-28. doi: 10.2165/00003088-199936050-00002. Clin Pharmacokinet. 1999. PMID: 10384857 Review.
Renal effects of COX-2-selective inhibitors.
Brater DC, Harris C, Redfern JS, Gertz BJ. Brater DC, et al. Among authors: gertz bj. Am J Nephrol. 2001 Jan-Feb;21(1):1-15. doi: 10.1159/000046212. Am J Nephrol. 2001. PMID: 11275626 Review.
Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial.
Jankovic J, Coffey B, Claassen DO, Jimenez-Shahed J, Gertz BJ, Garofalo EA, Stamler DA, Wieman M, Savola JM, Gordon MF, Alexander J, Barkay H, Harary E. Jankovic J, et al. Among authors: gertz bj. JAMA Netw Open. 2021 Oct 1;4(10):e2128204. doi: 10.1001/jamanetworkopen.2021.28204. JAMA Netw Open. 2021. PMID: 34609495 Free PMC article. Clinical Trial.
Rationale for the use of alendronate in osteoporosis.
Kanis JA, Gertz BJ, Singer F, Ortolani S. Kanis JA, et al. Among authors: gertz bj. Osteoporos Int. 1995 Jan;5(1):1-13. doi: 10.1007/BF01623652. Osteoporos Int. 1995. PMID: 7703618 Review.
Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial.
Coffey B, Jankovic J, Claassen DO, Jimenez-Shahed J, Gertz BJ, Garofalo EA, Stamler DA, Wieman M, Savola JM, Gordon MF, Alexander JK, Barkay H, Harary E. Coffey B, et al. Among authors: gertz bj. JAMA Netw Open. 2021 Oct 1;4(10):e2129397. doi: 10.1001/jamanetworkopen.2021.29397. JAMA Netw Open. 2021. PMID: 34661664 Free PMC article. Clinical Trial.
Pharmacokinetics of intravenous alendronate.
Cocquyt V, Kline WF, Gertz BJ, Van Belle SJ, Holland SD, DeSmet M, Quan H, Vyas KP, Zhang KE, De Grève J, Porras AG. Cocquyt V, et al. Among authors: gertz bj. J Clin Pharmacol. 1999 Apr;39(4):385-93. doi: 10.1177/00912709922007958. J Clin Pharmacol. 1999. PMID: 10197297 Clinical Trial.
Clinical pharmacology of alendronate sodium.
Gertz BJ, Holland SD, Kline WF, Matuszewski BK, Porras AG. Gertz BJ, et al. Osteoporos Int. 1993;3 Suppl 3:S13-6. doi: 10.1007/BF01623002. Osteoporos Int. 1993. PMID: 8298197
Studies of the oral bioavailability of alendronate.
Gertz BJ, Holland SD, Kline WF, Matuszewski BK, Freeman A, Quan H, Lasseter KC, Mucklow JC, Porras AG. Gertz BJ, et al. Clin Pharmacol Ther. 1995 Sep;58(3):288-98. doi: 10.1016/0009-9236(95)90245-7. Clin Pharmacol Ther. 1995. PMID: 7554702 Clinical Trial.
78 results